Cardiac Amyloidosis as a Potential Confounder in Heart Failure With Preserved Ejection Fraction Trials

JACC Heart Fail. 2017 Aug;5(8):617. doi: 10.1016/j.jchf.2017.04.006.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amyloidosis
  • Heart Failure*
  • Humans
  • Natriuretic Peptides
  • Spironolactone*
  • Stroke Volume

Substances

  • Natriuretic Peptides
  • Spironolactone